Eisai (OTCMKTS:ESALY) Stock Passes Above Fifty Day Moving Average – Here’s What Happened
by Doug Wharley · The Cerbat GemEisai Co., Ltd. (OTCMKTS:ESALY – Get Free Report) shares crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $61.51 and traded as high as $63.29. Eisai shares last traded at $61.51, with a volume of 331,800 shares traded.
Eisai Trading Down 2.1%
The stock has a market cap of $17.64 billion, a price-to-earnings ratio of 70.70, a P/E/G ratio of 2.46 and a beta of 0.31. The business’s fifty day simple moving average is $61.51 and its 200 day simple moving average is $61.51. The company has a debt-to-equity ratio of 0.10, a current ratio of 2.20 and a quick ratio of 1.77.
About Eisai
Eisai Co, Ltd. is a research-driven global pharmaceutical company headquartered in Tokyo, Japan. Founded in 1941 by Toyoji Naito, Eisai focuses on the discovery, development, manufacture and commercialization of prescription medicines and related healthcare products. The company emphasizes neuroscience and oncology as core therapeutic areas and invests in both small-molecule and biologic research to address unmet medical needs.
Among its well-known products, Eisai developed and markets Aricept (donepezil), a widely used treatment for the symptoms of Alzheimer’s disease, and LENVIMA (lenvatinib), an oncology therapy for several tumor types.
Further Reading
- Five stocks we like better than Eisai
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?